期刊文献+

Graves病女性患者择期怀孕的临床观察

Observe the time selecting pregnant for Graves disease female patients
下载PDF
导出
摘要 目的探讨寻找一个合适的方案,解决Graves病患者急于怀孕的问题。方法甲亢治疗初始阶段选用甲巯咪唑并做好避孕措施,在甲亢控制稳定并且所用药量比较少的时候改用PTU,以最小维持量控制甲亢,若病情稳定不停药的基础上准备怀孕。结果可以缩短从甲亢治疗到怀孕的时间,妊娠中后期大部分患者可以停药。 Objective Observe the time selecting pregnant for graves disease female patients. Methods During the early treatment,use the methmazole,and the patients need to contraception. When the patients are in remission,and the dosage of mathmazole was very small,change to use propylthiouracil,if the function of thyroid becomes normal and steady,tell the patients could be pregnant. Results Can short the time from the treatment of hyperthyroidism to pregnant,during the second and last trimester gestation,most of the patients could stop taking propylthiouracil. Conclusion The method has good effect,it is worth using for reference.
出处 《中国实用医药》 2013年第20期70-71,共2页 China Practical Medicine
关键词 GRAVES病 择期怀孕 甲巯咪唑 丙基硫氧嘧啶 Graves disease The time selecting pregnant Propylthiouracil Methimazol
  • 相关文献

参考文献4

二级参考文献156

  • 1Chan GW, Mandel SJ. Therapy insight: management of Graves' disease during pregnancy. Nat Clin Pract Endocrinol Metab, 2007, 3(6) :470-478.
  • 2Abalovich M, Amino N, Barbour LA, et al. Management of thyroid dysfunction during pregnancy and postpartum:an endocrine society clinical practice guideline. J Clin Endocrinol Metab, 2007, 92(8 Suppl):S1-47.
  • 3Casey BM, Dashe JS, Wells CE, et al. Subclinical hyperthyroidism and pregnancy outcomes. Obstct Gynecol, 2006, 107(2 Pt 1 ) :337-341.
  • 4Anselmo J, Cao D, Karrison T, et al. Fetal loss associated with excess thyroid hormone exposure. JAMA, 2004, 292 (6) :691-695.
  • 5Spencer CA, Lee R, Kazarosyan M, et al. Thyroid reference ranges in pregnancy:Studies on an iodine sufficient cohort. Thyroid, 2005, 15 ( Suppl 1 ) : 1-16.
  • 6Sapin R, D' Herbomez M, Schlienger JL. Free thyroxine measured with equilibrium dialysis and nine immunoassays decreases in late pregnancy. Clin Lab, 2004, 50 (9-10) : 581-584.
  • 7Casey BM, Dashe JS, Wells CE, et al. Subclinical hypothyroidism and pregnancy outcomes. Obstet Gynecol, 2005, 105 (2) :239-245.
  • 8Haddow JE, Knight GJ, Palomaki GE, et al. The reference range and within-person variability of thyroid stimulating hormone during the first and second trimesters of pregnancy. J Med Screen, 2004, 11 (4) :170-174.
  • 9Luton D, Le Gac I, Vuillard E, et al. Management of Graves' disease during pregnancy:the key role of fetal thyroid gland monitoring. J Clin Endocrinol Metab, 2005, 90 ( 11 ) :6093-6098.
  • 10Momotani N. Anti-thyroid drug therapy for Graves' disease during pregnancy:mildest thyrotoxic maternal free thyroxine concentrations to avoid fetal hypothyroidism. The 77th Annual Meeting of the American Thyroid Association, 2006, Phoenix, AZ.

共引文献657

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部